基礎運動能力檢査의 妥當度 및 評價基準分析

黃喆文,金重雄,表內淑,黃太相 釜山大學校 附設 體育科學硏究所 1988 體育科學硏究所 論文集 Vol.4 No.-

In administrating 323 subjects (man : 294, woman : 29) for admission to the department of physical education, college of education, Pusan National University during two years, the General Motor Ability Test was measured in order to analyze the validity and reliability of evaluation norm in choosing events and grading. The subjects were tested in seven events : 1) 100m Dash, 2) 1500m Run(man), 800m(woman), 3) Throwing Hand-Ball, 4) Broad jump, 5) Chinning(man), Flexed-Arm Hang(woman), 6) Zig-Zag Run, 7) Trunk Flexion. The results are as followes ; 1. In 100m Dash, 1500m Run, and Throwing Hand-Ball, man's average recordes were shown normal distribution which was inclined towgrd low 11 grade. So it was analyzed that we must regulate the interval size to lower. 2. Average records of Broad Jump in were distributed into the somewhat high (3-7) grade (about 78.6%). Then, the interval size must be regulated higher. 3. In chinning, Zig-Zag Run, and Trunk Flexion man's average records were shown normal distribution, and the average and the standard deviation were similar to present records. 4. For woman, it was impossible to analyze correctly in all seven because of the small number of subjects. So it was analyzed for the sake of the reference. There will be an exact analization in choosing the interval size and standard records. 5. Investigating the validity of the choosing seven events. We found out that 100m Dash was chosely interrelated with others, and so it was the dependent event. But other events were independent. Then, we could say that they were chosen reasonably.

釜山大 男學生의 體力 및 身體遂行 能力에 關한 硏究

金泰運,徐國雄,金命祚,趙福德,黃喆文 釜山大學校 附設 體育科學硏究所 1988 體育科學硏究所 論文集 Vol.4 No.-

The purpose of this study was measure height, weight, chest girth, sit and reach, grip strength, back strength, % body fat and VO₂max for freshman students majoring in engineering in Puasn National University. In comparison with the results of other studies, the following conclusion were drawn. A. Height(172 ±4㎝) and weight(62 ±7㎏) were increased, but chest girth(87 ±6㎝) decreased. B. VO₂max(2.4 ±0.31/min 38 ±38 ±6ml/㎏/min) and % body fat (7 ±4%) were significantly low. C. Questionaire revealed 16% of subjects exercise 4∼5 hours per week D. Questinmaire revealed that smokers and drinkers are 18%, 86% respectively.

영암댐의 어도를 이용하는 회유성 어류 자원의 계절적 변화 연구

오철웅,황종서,박경양,송태곤 木浦大學校 沿岸環境硏究所 1999 沿岸環境硏究 Vol.16 No.1

영암호 통선겸용 갑문식 어도에서 총 30회의 어류 조사 결과 줄공치, 웅어, 숭어, 빙어, 전어 등 총 25종이 출현하였다. 어도의 출현 종은 계절별로 종조성, 개체수, 생체량에 있어서 크게 변동하는 것을 보여 주었다. 월별 총출현 종수는 6월에 12종으로 가장 많은 종이 출현하였으며, 다음으로 7, 8, 9월에 11종, 10월에 10종이었으며, 11월에 6종, 4월과 5월에 각각 5종으로 가장 적은 종수의 출현하였다. 종다양도지수 또한 6월에 1.048로 가장 높았으며, 11월에 0.346으로 가장 낮게 나타났다. 출현종의 개체수는 봄철이후로 전반적인 감소 경향을 보여 주었으며, 주요 우점종의 전체 개체수는 줄공치, 웅어, 빙어, 숭어의 순으로 나타났다. 생체량도 개체수의 변화와 마찬가지로 봄철이후로 전반적인 감소 경향을 보여 주었으며, 주요 우점종에 대한 전체 비율를 보면 웅어, 줄공치, 빙어, 숭어의 순으로 나타났다. 이러한 영암호 통선겸용 갑문식 어도에서 어도 이용 생물의 종조성, 개체수 및 생체량의 뚜렷한 계절적인 변화 (temporal variation)를 관찰 할 수 있었다. 이러한 결과는 계절별로 다양한 종들이 그들의 생활사의 일부 기간에 어도를 효과적으로 이용하고 있다는 것을 반영해 주었다. 우점종의 한종인 줄공치의 체장빈도분포 분석결과 줄공치는 두개의 연급군으로 이루어져 있으며, 두번째 연급군이 탁월 연급군이었다. 가입은 주로 여름철 (8월과 9월)에 일어났다. 이러한 결과는 줄공치가 치어기부터 성어기까지 어도를 이용하고 있다는 것을 지적해 주고 있다. Investigations were made on the temporal changes in species composition and species diversity, number of individuals and biomass of fishes in the fish way constructed at Young-am Dam. During the sampling period total 25 species were observed. Of these, dominant species were Hemiramphus kurumaeus, Coilia ectenes, Mugil cephalus, and Hypomesus olidus. Number of species was the most numerous in June (12) and the least in April and May (5). Similar results were found in the species diversity index (H'), which was 1.048 in June and 0.346 in November. There were variations in number of Individuals and biomass of fishes in the fish way, showing a gradual decline from summer to Autumn. This suggests that a variety of adult and larval fishes utilized in the fish way as a channel of migration in relation to their life history. Number of individuals (percentage of total number) was in the order of Hemiramphus kurumaeus (63%), Coilia ectenes (17%), Hypomesus olidus (15%), Mugil cephalus (5%) and biomass (percentage of total biomass) in the order of Coilia ectenes (51%), Hemiramphus kurumaeus (35%), Hypomesus olidus (7%), Mugil cephalus (4%). For one of the dominant species, Hemiramphus kurumaeus, length-frequency distribution showed that it consisted of two cohorts, with predominance in the 2nd cohort and recruitment occurred mainly in August and September, indicating utilization of fish way at various stages during its life history.

師範系 體育敎育科 志望生의 一般運動能力檢査 基準値 設定에 關한 硏究

梁點紅,高基俊,黃喆文,金泰運,金重雄,白永鎬,表內淑,黃太相,徐國雄 釜山大學校 附設 體育科學硏究所 1989 體育科學硏究所 論文集 Vol.5 No.-

This study was analyzed the validity and the reliability of evaluation norm. which was used in choosing and grading events of the General Motor Ability Test. The General Motor Ability Test has been done for applicants for entrance to the department of physical education, college of education, Pusan National University. The subjects of this study were 433 applicants(men :387, women :46) for three years. They were tested in seven events : 1) 100m Dash, 2) 1500m Run(man), 800m Run (woman), 3) Throwing Hand-Ball, 4) Broad Jump, 5) Chinning(man), Flexed-Arm Hang(woman), 6) Zig-Zag Run, 7) Trunk Flexion. The results could be summerized as follows ; 1. In 100m Dash, 1500m Run, and Throwing Hand-Ball, man's average records were shown normal distribution which was inclined toward low ll grade. Therefore, the interval size of those three events must be regulated to lower. 2. Average records of Broad Jump in man were distributed into high (1) grade. So, the interval size must be adjusted to higher. 3. In Chinning, Zig-Zag Run, ad Trunk Flexion, man's average records were shawn normal distribution, and the interval size was similar to present records. 4. For woman, it was impossible to analyze correctly in all seven events because of the small number of subjects. So, it was for the sake of the reference. 5. The record of applicants for three years were operated to the variable quantity analysis. And the restults were these ; 100m Dash was F=3.0865(p<0.05), Chinning F=3.9309(p<0.05), Broad Jump F=14.7338(p<0.001), Throwing Hand-Ball F=4.9716(p<0.01), and Zig-Zag Run F=6.8297(p<0.001). Then, it was shown statistical meaningful difference in three groups. 6. In investigating the validity in choosing seven events, it was concluded that the events have been chosen reasonably. Because all events except for 100m Dash, and Zig-Zag Run in man were independent. From the analysis of the General Motor Ability Test, we could realized the necessity of regulating the standard and the interval size in several events. Then, we proposed the new evaluation norm which was suitable to present situation.

급성 호흡곤란으로 내원한 성대기능이상 1례

함초롬,박경일,박혜연,황철웅,김종연,김태년,진재용,이성순 白中央醫療院 2005 仁濟醫學 Vol.26 No.1

Vocal cord dysfunction (VCD) is a respiratory disorder characterized by the abnormal adduction of the vocal cords upon inspiration, expiration, or both, leading to a diverse array of acute obstructive airway signs and symptoms (wheezing, chest tightness, shortness of breath, and cough). VCD frequently mimics or confounds asthma. Misdiagnosis as asthma has led to inappropriate treatment, most notably with high-dose corticosteroids. Mistaken for anaphylaxis or angioedema, VCD has led to intubation and tracheostomy. VCD should be suspected in patients who are treated aggressively for asthma but continue to experience dyspnea. The diagnosis of VCD is made from direct visualization of the vocal cords during an attack. Inspiratory, anterior vocal cord closure with a posterior glottic chink is seen. On pulmonary function testing, a pattern of "saw-toothing", or fluttering of the inspiratory limb, representing fluctuations in the abnormal cord motion is seen in VCD patient. Treatment includes discussion of the diagnosis with the patients, discontinuing unnecessary medications, using of a helium-oxygen mixture in acute attack. Speech therapy and psychotherapy are the mainstays of long-term treatment. Here in we report a case of VCD in company with asthma.

호르몬 불응성 전립선암 환자에서 mitoxantrone과 prednisone의 병합화학요법 후 통증완화 및 삶의 질 측정

이홍우,이지열,김세웅,이충범,강성학,조용현,황태곤,박용현,윤문수 대한화학요법학회 2000 대한화학요법학회지 Vol.18 No.3

목적 : 호르몬 불응성 전립선암 환자의 생명을 연장시키는 치료법은 현재로는 없으며, 현 시점에서의 치료목표는 증상의 경감 및 소실에 따른 삶의 질 향상에 두고 있다. 호르몬 불응성 전립선암의 고식적인 치료에 일차적인 치료법으로 간주되는 mitoxantrone과 prednisone의 화학요법이 호르몬 불응성 전립선암 환자의 통증완화 및 삶의 질에 어떠한 영향을 미치는지 알아보았다. 방법 : 1998년 7월부터 1999년 12월까지 증상이 있는 18명의 호르몬 불응성 전립선암 환자를 대상으로 하였으며, 일차적인 치료의 목표는 환자 본인이 기록하는 McGill-Melzack 6단계 통증척도에서 진통제의 증량 없이 2점이 감소(또는 첫 점수가 1점일 경우 통증의 완전소실)하는 것으로 하였다. 이러한 기준은 최소 3주 간격으로 시행한 자가 기록조사에서 연속적으로 2번 이상 유지될 때 유효한 것으로 간주하였다. 건강과 관련된 삶의 질 측정은 전신적 치료의 임상적 응용을 위한 실제적인 측정방법으로 개발되어 환자가 직접 작성하는 전립선암 특이성 삶의 질 측정기구(Prostate Cancer-Specific Quality-of-Life Instrument : PROSQOLI)의 비례연속형의 자가측정 척도(linear analogue self-assessment scale : LASA)를 이용하였으며, ECOG performance status를 사용하여 전신상태의 변화도 측정하였다. 결과 : 통증의 경감으로 나타나는 고식적인 치료의 반응은 66.7%(12/18)에서 나타났으며, 반응의 지속기간은 2개월에서 10개월까지로 평균 4.2±3.6개월이었다. PROSQOLI로 측정한 삶의 질은 통증에 대한 고식적인 치료반응을 보인 12명(66.7%) 모두가 삶의 질이 개선되었으며 특히 통증, 변비, 소변보기, 전반적인 복지상태에서의 유의한(p<0.05) 증가를 보였다. 치료 후 혈장 PSA 수치는 고식적인 반응의 유무에 관계없이 별 다른 변화를 보이지 않았으며, 골주사 또는 전산화 단층촬영으로 측정한 방사선학적 병변은 고식적인 반응을 보인 2명을 제외하고 치료 전과 비교하여 차이를 보이지 않았다. 병합 화학요법과 관련된 특별한 부작용은 관찰되지 않았다. 결론 : 통증을 동반한 호르몬 불응성 전립선암에서 mitoxantrone과 prednisone의 병합화학요법은 66.7%의 환자에서 통증의 감소 및 삶의 질이 향상되었다. 현재는 혈장 PSA 수치, 병소의 크기나 개수등이 치료의 지침이나 치료결과의 판정을 위한 객관적인 기준으로 사용되는 경향이 있지만, 앞으로는 환자를 중심으로 통증을 포함한 삶의 질 측정이 고식적 치료 후 치료결과 판정에 있어 객관적이고 적절한 방법이 될 것이다. Background : There is no evidence that therapeutic modalities prolong the survival of patients with hormone-refractory prostate cancer nowadays. The main goal of treatment is therefore improvement in quality-of-life including palliation of symptoms. We performed this study to investigate the benefit of mitoxantrone and prednisone chemotherapy in patients with symptomatic hormone-refractory prostate cancer using relevant end points of palliation regarding to pain and quality-of-life. Methods : From July 1998 to December 1999, we assessed the 18 patients with symptomatic hormone-refractory prostate cancer receiving mitoxantrone and low dose prednisone. The treatment end point was a palliative response defined as a 2-point decrease in pain assessed by a 6-point pain scale complemented by patients (or complete loss of pain if initially 1+) without an increase in analgesic medication and maintained for two consecutive evaluations at least 3 weeks apart. Health-related quality-of-life was evaluated with a series of linear analogue self-assessment(LASA) scale of the Prostate Cancer-Specific Quality-of-Life Instrument (PROSQOLI) and performance status was also measured. Results : Palliative responses were observed in 12(66.7%) of 18 patients. The duration of palliative responses were 4.2±3.6 months(range: 2 to 10 months). Treatment was well tolerated without specific side effects. There were no differences in prostate-specific antigen (PSA) level following treatment and no significant changes of radiologic findings evaluated by bone scan and/or CT were noted except 2 cases after chemotherapy. All the responding patients had an improvement in quality-of-life scales and performance status, however serum PSA levels were not changed. Conclusions : Chemotherapy with mitoxantrone and prednisone provides palliation and an improvement in quality-of-life for more than half (66.7%) of the patients with symptomatic hormone-refractory prostate cancer.

발열로 인해 발현된 부루가다 증후군 1례

박혜연,김종훈,박경일,황철웅,김태년,남궁준,도준형,이원로,이성윤 白中央醫療院 2005 仁濟醫學 Vol.26 No.1

Brugada syndrome is characterized by right bundle branch block morphology and ST segment elevation in the right precordial leads and a propensity to develop ventricular arrhythmias. Mutations in a cardiac sodium channel gene have been linked to this syndrome, and the ionic mechanisms responsible for the electrocardiographic phenotype are temperature-dependent. This case report describes a patient in whom a typical Brugada ECG pattern developed during fever and returned normal ECG after fever was subsided.

진단 초음파를 이용한 정상 성인의 정중신경 측정

이정아,임길병,이홍재,정웅태,황현오 최신의학사 2003 最新醫學 Vol.46 No.11-12

Impact of postoperative duration of Aspirin use on longevity of bioprosthetic pulmonary valve in patients who underwent congenital heart disease repair

Hwang, Tae-Woong,Kim, Sung-Ook,Lee, Sang-Yun,Kim, Seong-Ho,Choi, Eun-Young,Jang, So-Ick,Park, Su-Jin,Kwon, Hye-Won,Lim, Hyo-Bin,Lee, Chang-Ha,Choi, Eun-Seok The Korean Pediatric Society 2016 Clinical and Experimental Pediatrics (CEP) Vol.59 No.11

Purpose: Generally, aspirin is used as a protective agent against thrombogenic phenomenon after pulmonary valve replacement (PVR) using a bioprosthetic valve. However, the appropriate duration of aspirin use is unclear. We analyzed the impact of postoperative duration of aspirin use on the longevity of bioprosthetic pulmonary valves in patients who underwent repair for congenital heart diseases. Methods: We retrospectively reviewed the clinical data of 137 patients who underwent PVR using a bioprosthetic valve between January 2000 and December 2003. Among these patients, 89 were included in our study and divided into groups I (${\leq}12$ months) and II (>12 months) according to duration of aspirin use. We analyzed echocardiographic data from 9 to 11 years after PVR. Pulmonary vale stenosis and regurgitation were classified as mild, moderate, or severe. Results: The 89 patients consisted of 53 males and 36 females. Their mean age was $14.3{\pm}8.9$ years (range, 2.6-48 years) and body weight was $37.6{\pm}14.7kg$ (range, 14-72 kg). The postoperative duration of aspirin use was $7.3{\pm}2.9$ months in group I and $32.8{\pm}28.4$ months in group II. However, no significant difference in sex ratio, age, body weight, type of bioprosthetic valve, and number of early redo-PVRs. In the comparison of echocardiographic data about 10 years later, no significant difference in pulmonary valve function was found. The overall freedom rate from redo-PVR at 10 years showed no significant difference (P=0.498). Conclusion: Our results indicated no benefit from long-term aspirin medication (>6 months) in patients who underwent PVR with a bioprosthetic valve.

Impact of postoperative duration of Aspirin use on longevity of bioprosthetic pulmonary valve in patients who underwent congenital heart disease repair

Tae-Woong Hwang,Sung-Ook Kim,Sang Yun Lee,Seong Ho Kim,Eun-Young Choi,So-Ick Jang,Su-Jin Park,Hye-Won Kwon,Hyo-Bin Lim,Chang-Ha Lee,Eun Seok Choi 대한소아청소년과학회 2016 Clinical and Experimental Pediatrics (CEP) Vol.59 No.11

Purpose: Generally, aspirin is used as a protective agent against thrombogenic phenomenon after pulmonary valve replacement (PVR) using a bioprosthetic valve. However, the appropriate duration of aspirin use is unclear. We analyzed the impact of postoperative duration of aspirin use on the longevity of bioprosthetic pulmonary valves in patients who underwent repair for congenital heart diseases. Methods: We retrospectively reviewed the clinical data of 137 patients who underwent PVR using a bioprosthetic valve between January 2000 and December 2003. Among these patients, 89 were included in our study and divided into groups I (≤12 months) and II (>12 months) according to duration of aspirin use. We analyzed echocardiographic data from 9 to 11 years after PVR. Pulmonary vale stenosis and regurgitation were classified as mild, moderate, or severe. Results: The 89 patients consisted of 53 males and 36 females. Their mean age was 14.3±8.9 years (range, 2.6–48 years) and body weight was 37.6±14.7 kg (range, 14–72 kg). The postoperative duration of aspirin use was 7.3±2.9 months in group I and 32.8±28.4 months in group II. However, no significant difference in sex ratio, age, body weight, type of bioprosthetic valve, and number of early redo-PVRs. In the comparison of echocardiographic data about 10 years later, no significant difference in pulmonary valve function was found. The overall freedom rate from redo-PVR at 10 years showed no significant difference (P=0.498). Conclusion: Our results indicated no benefit from long-term aspirin medication (>6 months) in patients who underwent PVR with a bioprosthetic valve.